In the BioHarmony Drug Report Database
Buspirone
Buspar (buspirone) is a small molecule pharmaceutical. Buspirone was first approved as Buspar on 1986-09-29. It is used to treat anxiety disorders, depressive disorder, and intellectual disability in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 1A. In addition, it is known to target 5-hydroxytryptamine receptor 7.
Trade Name
|
Buspar |
|---|---|
Common Name
|
buspirone |
ChEMBL ID
|
CHEMBL49 |
Indication
|
anxiety disorders, depressive disorder, intellectual disability |
Drug Class
|
Anxiolytics (buspirone type) |
Image (chem structure or protein)